Back
Roper Technologies 10K Form
Buy
60
ROP
Roper Technologies
Last Price:
$569.58
Seasonality Move:
8.42%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-03 | 10Q | ROP/Roper Technologies Quarterly |
2024-02-22 | 10K | ROP/Roper Technologies Annual |
2023-11-02 | 10Q | ROP/Roper Technologies Quarterly |
2023-08-03 | 10Q | ROP/Roper Technologies Quarterly |
2023-05-03 | 10Q | ROP/Roper Technologies Quarterly |
2023-02-27 | 10K | ROP/Roper Technologies Annual |
Receive ROP News And Ratings
See the #1 stock for the next 7 days that we like better than ROP
ROP Financial Statistics
Sales & Book Value
Annual Sales: | $7B |
---|---|
Cash Flow: | $683.8M |
Price / Cash Flow: | 26.93 |
Annual Sales: | $175.84 |
Price / Book: | 3.24 |
Profitability
EPS (TTM): | 14.34000 |
---|---|
Net Income (TTM): | $1.5B |
Gross Margin: | $4.9B |
Return on Equity: | 8.54% |
Return on Assets: | 5.13% |
Roper Technologies Earnings Forecast
Key Roper Technologies Financial Ratios
-
The Gross Profit Margin over the past 34 years for ROP is 69.30%.
-
The Selling, General & Administrative Expenses for ROP have been equal to 40.94% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 16.73% of Operating Income.
-
The Net Earning history of ROP is 22.01% of Total Revenues.
-
Per Share Earnings over the last 34 years have been positive in 23 years.
Roper Technologies Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Software |
Sector: | Information Technology |
Current Symbol: | ROP |
CUSIP: | 776696 |
Website: | ropertech.com |
Debt
Debt-to-Equity Ratio: | 0.4 |
---|---|
Current Ratio: | 0.4 |
Quick Ratio: | 0.32 |
Price-to-Earnings
Trailing P/E Ratio: | 39.67 |
---|---|
Forward P/E Ratio: | 26.32 |
ROP Technical Analysis vs Fundamental Analysis
Buy
60
Roper Technologies (ROP)
is a Buy
Is Roper Technologies a Buy or a Sell?
-
Roper Technologies stock is rated a BuyThe current Roper Technologies [ROP] share price is $569.29. The Score for ROP is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.